• PP2A-Modulated Autophagy Drives Drug Resistance in C. albica

  2026-05-18

  This study reveals that protein phosphatase 2A (PP2A) regulates autophagy via ATG protein phosphorylation in Candida albicans, promoting biofilm formation and antifungal drug resistance. Targeting PP2A-mediated autophagy, such as with mTOR inhibitors like Rapamycin, may offer new strategies for overcoming biofilm-associated resistance.

• GDC-0941: Strategic Insights for Translational PI3K Inhibiti

  2026-05-18

  This thought-leadership article unpacks the mechanistic rationale and translational impact of GDC-0941, a potent and selective PI3K inhibitor targeting class I isoforms. Blending primary literature, workflow guidance, and clinical context, we explore how GDC-0941—available from APExBIO—serves as a pivotal tool for dissecting PI3K/Akt pathway inhibition, overcoming resistance in cancer models, and guiding next-generation therapeutic strategies. The analysis is anchored in contemporary findings on pathway crosstalk, resistance mechanisms, and the evolving landscape of oncology research.

• Tetracycline in Advanced Ribosomal and ER Stress Assays

  2026-05-17

  Tetracycline, a broad-spectrum polyketide antibiotic from APExBIO, powers precise antibiotic selection and ribosomal function studies. Explore how its unique mechanistic features and robust purity drive innovation in ER stress modeling, with evidence-based guidance for optimizing workflows and troubleshooting persistent experimental challenges.

• Machine Learning Reveals Senescence-Inducing Compounds in Gl

  2026-05-16

  This study pioneers a machine learning approach for identifying senescence in glioblastoma cells using DAPI imaging, enabling high-throughput discovery of senescence-inducing compounds. The findings advance both phenotypic screening and mechanistic research into senescence as a therapeutic strategy in aggressive brain cancer.

• WTAP Overexpression Drives Poor Prognosis in AML via m6A-MYC

  2026-05-15

  This study uncovers that Wilms’ tumor 1-associated protein (WTAP) is highly expressed in acute myeloid leukemia (AML) and predicts poor prognosis by regulating m6A methylation of MYC mRNA. The findings clarify WTAP’s epigenetic role in AML progression and resistance, providing a mechanistic basis for targeted research into mRNA modification and leukemia therapy.

• Microglial Nr4a1–C3 Axis Links TMJ Inflammation to Depressio

  2026-05-15

  This study unveils how microglial Nr4a1 deficiency and neuronal C3 upregulation mediate hippocampal synaptic pruning and depression-like behaviors following TMJ inflammation. The findings illuminate a mechanistic neuroimmune pathway underlying emotional complications in TMD and suggest new molecular targets for intervention.

• RNASEH1-AS1 as a Prognostic lncRNA Biomarker in Hepatocellul

  2026-05-14

  This study identifies the long non-coding RNA RNASEH1-AS1 as an independent prognostic and diagnostic biomarker in hepatocellular carcinoma (HCC), revealing its oncogenic roles and molecular interactions. The work integrates bioinformatic and experimental approaches, providing new insights into HCC progression and actionable targets for future research.

• Ranolazine: Redefining Cardiac Metabolism and Immunometaboli

  2026-05-14

  Explore how Ranolazine, a leading anti-ischemic agent, uniquely bridges cardiac metabolism and innate immune signaling. This article delivers a deep scientific exploration of Ranolazine’s metabolic modulation, practical assay guidance, and fresh perspectives on immunometabolic research.

• Lipidated Nanophotosensitizers Disable Tumor Extracellular V

  2026-05-13

  The referenced study introduces a lipidated nanophotosensitizer that traces and disables tumor extracellular vesicles (TEVs) to concurrently inhibit tumor growth and metastasis. This dual-function approach addresses the persistent challenge of selectively targeting TEV-mediated communication in cancer, offering a new paradigm for antimetastatic therapy.

• Microraft Array Screening Reveals Heterogeneity in Human Gas

  2026-05-13

  This study introduces an automated microraft array platform for high-throughput screening and sorting of single gastruloids derived from human pluripotent stem cells, enabling quantitative analysis of chromosomal mosaicism during early embryogenesis. By integrating phenotypic imaging and transcriptomics, the research advances understanding of self-organization and mechanisms underlying aneuploidy depletion, with implications for improving embryo assessment in reproductive medicine.

• Glutamine-STAT3-PD-L1 Axis in Pancreatic Cancer Regulation

  2026-05-12

  The referenced study uncovers how glutamine availability regulates PD-L1 expression through STAT3 signaling in pancreatic cancer. This mechanism links metabolic homeostasis to immune checkpoint modulation, suggesting new avenues for targeted therapies and metabolic-immune interplay research.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-12

  The Hoechst 33342/PI Double Staining Kit provides a direct, dual-fluorescence method for distinguishing viable, apoptotic, and necrotic cells in basic research. It is best suited for fluorescence microscopy workflows requiring assessment of chromatin condensation and membrane integrity. This kit is not intended for diagnostic or clinical use.

• Multi-Omics Dissects ARID1A-Driven Resistance in Melanoma

  2026-05-11

  This study leverages integrative multi-omics to unravel the mechanisms by which loss of ARID1A drives resistance to BRAF/MAPK inhibitors in melanoma. The findings identify key signaling nodes and immune evasion pathways, offering new insights for overcoming acquired resistance and improving targeted therapeutic strategies.

• D2-like Dopamine Receptor Activation Restores Network Functi

  2026-05-11

  This study demonstrates that activation of D2-like dopamine receptors reverses impaired hippocampal γ oscillations and cognitive deficits in a mouse model of infantile neuronal ceroid lipofuscinosis (INCL) caused by PPT1 deficiency. The findings identify specific dopamine receptor subunits as potential therapeutic targets for neurodegenerative lysosomal storage disorders.

• Bleomycin Sulfate (SKU A8331): Reliable Solutions for DNA Da

  2026-05-10

  This article delivers scenario-driven, evidence-based guidance for deploying Bleomycin Sulfate (SKU A8331) in cell viability, chemotherapy-induced DNA damage, and pulmonary fibrosis research. Through real-world Q&A, it demonstrates how researchers can leverage validated protocols and literature-backed selectivity to overcome common laboratory challenges and generate reproducible results.

16104 records 7/1074 page Previous Next First page 上5页 678910 下5页 Last page